Friday, October 05, 2007
Health Canada pulls market approval for drug Prexige, citing liver problems
TORONTO - Health Canada has ordered the anti-inflammatory drug Prexige off the market, citing the potential for severe liver-related side-effects....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment